The closing paragraph of the FDAs evaluation of BPC-157
1 2 1 3 , , , , - (Glutathione Results Timeline Table) (Before & After Expectations) (Before & After Expectations) , , - , (Side Effects & Safety Precautions) , , : - , - , Glutathione ()
About Danuglipron Danuglipron (PF-06882961) is an investigational medicine that is taken as a tablet by mouth and is not approved for use by health authorities at this time
The bigger risk is that carbohydrate intake triggers cravings that make returning to keto difficult, particularly if appetite suppression from the medication is not strong enough to override the carbohydrate-driven hunger signal